Uploaded on Jan 31, 2023
Hemophilia is a hereditary genetic blood disorder that affects the capacity of the blood to clot due to the lack of a particular protein needed for blood clotting. The hemophilia is graded as Hemophilia A, Hemophilia B, and C. Many recombinant drugs, such as an antihemophilic factor or Factor VII, are injectable. Read More:- https://www.theinsightpartners.com/reports/hemophilia-treatment-market
Hemophilia Treatment Market Competitive Landscape, Trends, Opportunities and Top Manufacturers
Hemophilia Treatment Market Global Analysis and Forecast to 2027
Published Date : Feb 2020
Email: [email protected]
Email: [email protected]
Report Studies
Hemophilia Treatment Market to 2027 - Global Analysis and Forecasts by Product
(Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor
Concentrates, Desmopressin, Antifibrinolytic Agents); Disease (Hemophilia A,
Hemophilia B, Hemophilia C); Treatment Type (On-demand, Prophylaxis); Therapy
(Replacement Therapy, ITI Therapy, Gene Therapy, Antibody Therapy); End User
(Hospitals, Clinics, Ambulatory Surgical Centres, Others), and Geography
2
Email: [email protected]
$50,000
Hemophilia Treatment
$40,000
Market Value
$30,000
CAGR of 6.1%
$20,000
(2020 to 2027)
$10,000
$0
20XX 20XX 20XX 20XX 20XX
3
Email: [email protected]
Hemophilia Treatment
Market Overview
The Hemophilia Treatment Market was valued at US$ 12,797.36 million in 2019 and it is
projected to reach US$ 20,507.92 million in 2027; it is expected to grow at a CAGR of 6.1%
from 2020 to 2027.
Hemophilia is a hereditary genetic blood disorder that affects the capacity of the blood to clot
due to the lack of a particular protein needed for blood clotting.
4
Email: [email protected]
Key Segment Market
Segment By Type:-
Product (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor
Concentrates, Desmopressin, Antifibrinolytic Agents)
Disease (Hemophilia A, Hemophilia B, Hemophilia C)
Treatment Type (On-demand, Prophylaxis)
Therapy (Replacement Therapy, ITI Therapy, Gene Therapy, Antibody Therapy)
End User (Hospitals, Clinics, Ambulatory Surgical Centres, Others) 5
Email: [email protected]
Company Profiles
Bayer AG
Sanofi
F. Hoffmann-la Roche Ltd.
Kedrion S.P.A.
CSL Limited
Biotest AG
Pfizer Inc.
Novo Nordisk A/S
Octapharma AG
Baxter International Inc.
6
Download Sample Her
e
Email: [email protected]
By Geography
North America (the US, Canada, and Mexico)
Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)
Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)
Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East &
Africa)
South & Central America (Brazil, Argentina, and the Rest of South & Central America).
7
THANK
YOU! Phone : +1-646-491-9876
E-Mail : [email protected]
Comments